mTOR Inhibition in the Management of Recurrent Metastatic Solid Pseudopapillary Tumor of the Pancreas
MAM serves on Terry Fox Research Institute's (TFRI) Research Council, Network Council, Canadian Spectrum Working Group, Technology Working Group (co-chair), Open Accrual Working Group, Digital Health Discovery Platform (co-chair), and as co-lead of the BC Cancer Consortium, which receives and allocates TFRI funding. TFRI provides funding support to his research program and trainees. R.J.D. has served on an advisory board for Bayer Inc.
Authors
- Daniel J. Renouf (ORCID: https://orcid.org/0000-0002-7597-6089)
- Jonathan W. Bush (ORCID: https://orcid.org/0000-0001-9432-2390)
- Philipp F. Lange (ORCID: https://orcid.org/0000-0003-1171-5864)
- Rebecca J. Deyell (ORCID: https://orcid.org/0000-0003-3315-4383)
- Claire Gowdy (ORCID: https://orcid.org/0009-0008-8054-0635)
- Tariq A. Bhat (ORCID: https://orcid.org/0000-0003-0738-8776)
- Veronika Csizmók
- Hannah G. Piper (ORCID: https://orcid.org/0000-0002-8379-2271)
- Janessa Laskin (ORCID: https://orcid.org/0000-0002-0161-9329)
- Marco A Marra
- Chris A. Maxwell
- C. James Lim
- Yaoqing Shen
- Gabrielle Herzenberg
- Gregor S. D. Reid
- S. Rod Rassekh
Institutions
- BC Cancer Agency (CA)
- University of British Columbia (CA)
- Canada's Michael Smith Genome Sciences Centre (CA)
- BC Children's Hospital (CA)
- Canadian Centre for Applied Research in Cancer Control (CA)
Publication Details
- Journal
- Pediatric Blood & Cancer
- Published
- 2025-12-30
- DOI
- https://doi.org/10.1002/1545-5017.70083
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00